UroGen Pharma
URGN
URGN
82 hedge funds and large institutions have $214M invested in UroGen Pharma in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 29 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 29
23% less capital invested
Capital invested by funds: $277M → $214M (-$63.5M)
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
Holders
82
Holding in Top 10
1
Calls
$1.34M
Puts
$1.31M
Top Buyers
| 1 | +$3.14M | |
| 2 | +$1.11M | |
| 3 | +$862K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$860K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$771K |
Top Sellers
| 1 | -$4.05M | |
| 2 | -$3.67M | |
| 3 | -$1.29M | |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$768K |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$690K |